metformin has been researched along with Interstitial Nephritis in 3 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To describe a concentration range in clinical samples after chronic use of metformin, metformin serum concentrations were determined in serum samples of 95 diabetic patients receiving daily doses of 500mg-3000mg of metformin." | 5.48 | Range of therapeutic metformin concentrations in clinical blood samples and comparison to a forensic case with death due to lactic acidosis. ( Hess, C; Madea, B; Stratmann, B; Tschoepe, D; Unger, M, 2018) |
| " To describe a concentration range in clinical samples after chronic use of metformin, metformin serum concentrations were determined in serum samples of 95 diabetic patients receiving daily doses of 500mg-3000mg of metformin." | 1.48 | Range of therapeutic metformin concentrations in clinical blood samples and comparison to a forensic case with death due to lactic acidosis. ( Hess, C; Madea, B; Stratmann, B; Tschoepe, D; Unger, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Tao, T | 1 |
| Yang, Y | 1 |
| Hu, Z | 1 |
| Hess, C | 1 |
| Unger, M | 1 |
| Madea, B | 1 |
| Stratmann, B | 1 |
| Tschoepe, D | 1 |
| Cavaglieri, RC | 1 |
| Day, RT | 1 |
| Feliers, D | 1 |
| Abboud, HE | 1 |
3 other studies available for metformin and Interstitial Nephritis
| Article | Year |
|---|---|
A novel HNF1B mutation p.R177Q in autosomal dominant tubulointerstitial kidney disease and maturity-onset diabetes of the young type 5: A pedigree-based case report.
Topics: Aftercare; Central Nervous System Diseases; Dental Enamel; Diabetes Mellitus, Type 2; Hepatocyte Nuc | 2020 |
Range of therapeutic metformin concentrations in clinical blood samples and comparison to a forensic case with death due to lactic acidosis.
Topics: Acidosis, Lactic; Adult; Aged; Aged, 80 and over; Chromatography, Liquid; Diabetes Mellitus, Type 2; | 2018 |
Metformin prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction.
Topics: Adenylate Kinase; Animals; Anti-Inflammatory Agents; Drug Evaluation, Preclinical; Fibrosis; Kidney | 2015 |